<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02466321</url>
  </required_header>
  <id_info>
    <org_study_id>06-U02</org_study_id>
    <nct_id>NCT02466321</nct_id>
  </id_info>
  <brief_title>Anatomical Shoulder™ Inverse/Reverse Study</brief_title>
  <official_title>Anatomical Shoulder™ Inverse/Reverse Post-Market Surveillance Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer, GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain outcomes data on the Anatomical Shoulder™&#xD;
      Inverse/Reverse System by analysis of standard scoring systems and radiographs.&#xD;
&#xD;
      Outcome data will be collected using the following standard scoring systems of which summary&#xD;
      statistics will be provided:&#xD;
&#xD;
        -  Constant and Murley Score to evaluate clinical parameters such as range of motion,&#xD;
           power, level of pain and functional ability.&#xD;
&#xD;
        -  SF-12 Physical and Mental Health Summary Measures (SF12 Questionnaire) comprising of&#xD;
           twelve questions to assess the subject's physical and mental health status which must be&#xD;
           answered by the patient.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-centre, non-comparative, prospective post-market surveillance study involving&#xD;
      orthopaedic surgeons skilled in shoulder replacement surgery. Each case enrolled will receive&#xD;
      an Anatomical Shoulder™ Inverse/Reverse implant. All system components are CE-marked and&#xD;
      commercially available. Patients will be selected according to the subject selection&#xD;
      criteria.&#xD;
&#xD;
      All patients will undergo pre-operative, intra-operative and post-operative physical&#xD;
      examination, radiographic evaluation according to the hospital's routine procedure and&#xD;
      collection of quality of life metrics. Follow-up evaluations are to be conducted at either 6&#xD;
      weeks or 6 months (according to the hospital's standard care plan) and thereafter at 1, 2, 5&#xD;
      and 10 years post hospital discharge.&#xD;
&#xD;
      There are 5 study centres taking part in this project enrolling in total a maximum of 160&#xD;
      patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Performance</measure>
    <time_frame>10 years</time_frame>
    <description>Constant &amp; Murley Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>10 years</time_frame>
    <description>Kaplan-Meier</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Cuff-tear Arthropathy</condition>
  <arm_group>
    <arm_group_label>Inverse / Reverse Shoulder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient treated with a inverse / reverse shoulder device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inverse/Reverse Shoulder Arthroplasty</intervention_name>
    <description>Implantation of the Anatomical Shoulder Inverse/Reverse System</description>
    <arm_group_label>Inverse / Reverse Shoulder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age - 18 years minimum.&#xD;
&#xD;
          -  Sex - male and female.&#xD;
&#xD;
          -  General Health - the patient should be able to undergo surgery and participate in a&#xD;
             follow-up program based upon physical examination and medical history.&#xD;
&#xD;
          -  Informed Consent - patient or patient's legal representative has signed a Patient&#xD;
             Informed Consent form.&#xD;
&#xD;
          -  Indications - Diagnosis of disease or trauma in the affected joint, including&#xD;
             cuff-tear arthropathy, failure of prior rotator cuff surgery and irreparable rotator&#xD;
             cuff tears associated with loss of glenohumeral stability with the indication for&#xD;
             total shoulder arthroplasty.&#xD;
&#xD;
          -  The deltoid muscle has to be intact in all 3 parts (clavicular, acromial as well as&#xD;
             spinal).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is skeletally immature.&#xD;
&#xD;
          -  Patient is pregnant.&#xD;
&#xD;
          -  Patient is unwilling or unable to cooperate in a follow-up program.&#xD;
&#xD;
          -  Patient shows one of the following medical conditions - Chronic fracture, Acute&#xD;
             fracture, Axillary nerve lesion, Severe loss of humeral or glenoid bone, Paralysis of&#xD;
             the deltoid muscle, Active Infection&#xD;
&#xD;
          -  Patient requires one of the following medical interventions - Implant Revision,&#xD;
             Glenoid bone grafting, Autografts&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Schaetti, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Zimmer Biomet, Jr. Clinical Project Lead</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Monica Antwerpen</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HELIOS ENDO-Klinik Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vitos Orthopädische Klinik Kassel</name>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinik Balgrist</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Pennine Acute Hospital NHS Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2015</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inverse Reverse Shoulder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Rotator Cuff Tear Arthropathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

